NCT00494767: Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs |
|
|
| Completed | 1 | 27 | Europe | GW869682, GSK189075, GSK189075-Placebo, GW869682-Placebo | GlaxoSmithKline | Diabetes Mellitus, Type 2, Obesity | 06/07 | 06/07 | | |
